Back to top

Citigroup Maintains Neutral Rating on KRYS, Lowers Price Target | KRYS Stock News

Citigroup Maintains Neutral Rating on KRYS, Lowers Price Target | KRYS Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Krystal Biotech, Inc. (KRYS)